Live feed
Filing
SC 13D
SC 13D0001104659-22-053860·ANTARES PHARMA, INC.
Schedule 13D ownership disclosure
MEDI JECT CORP /MN/
Security class unavailable · CUSIP: 036642106
Event date: 2022-04-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.7300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-053860
- Form type
- SC 13D
- Filer
- ANTARES PHARMA, INC.
- CIK
- CIK 1016169
- Filed
- May 02, 2022
- Reporting period
- Apr 20, 2022
- Description
- Schedule 13D beneficial ownership